Net profit of Par Drugs & Chemicals rose 727.59% to Rs 4.80 crore in the quarter ended December 2025 as against Rs 0.58 crore during the previous quarter ended December 2024. Sales rose 37.23% to Rs 29.34 crore in the quarter ended December 2025 as against Rs 21.38 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales29.3421.38 37 OPM %20.626.64 - PBDT7.371.68 339 PBT6.440.77 736 NP4.800.58 728 Powered by Capital Market - Live News

Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 10 February 2026.Powered by Capital Market - Live News

Net profit of Par Drugs & Chemicals declined 51.98% to Rs 4.13 crore in the quarter ended September 2025 as against Rs 8.60 crore during the previous quarter ended September 2024. Sales declined 17.31% to Rs 28.66 crore in the quarter ended September 2025 as against Rs 34.66 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales28.6634.66 -17 OPM %21.1432.92 - PBDT6.4912.40 -48 PBT5.5511.49 -52 NP4.138.60 -52 Powered by Capital Market - Live News

Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live News

Par Drugs & Chemicals announced that the 26th Annual General Meeting(AGM) of the company will be held on 27 September 2025.Powered by Capital Market - Live News